BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)

Issues related to drug pricing and value, generally Issues related to pharmacy benefit managers and drug rebate reform Issues related to drug patents and patent reporting requirements Reauthorization of the Pandemic All-Hazards Preparedness Act Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517) Issues related to the Inflation Reduction Act (Pub. L. 117-169)

Issues related to reimbursement under Medicare Part B Issues related to Medicare Part D, generally Issues related to the 340B Drug Pricing Program